Invesco Ltd. - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 90 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$35,536
-62.4%
12,469
-3.9%
0.00%
Q4 2022$94,479
+5.0%
12,978
+15.5%
0.00%
Q3 2022$90,000
+63.6%
11,241
+1.3%
0.00%
Q2 2022$55,000
-99.0%
11,100
-95.0%
0.00%
-100.0%
Q1 2022$5,284,000
+178.0%
223,460
+107.9%
0.00%
Q4 2021$1,901,000
-88.7%
107,467
-82.0%
0.00%
-100.0%
Q3 2021$16,815,000596,0570.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$32,054,00014.00%
TRV GP IV, LLC 2,343,154$18,956,00011.08%
Logos Global Management LP 1,950,000$15,776,0001.94%
COWEN AND COMPANY, LLC 2,347,989$18,995,0001.82%
VR Adviser, LLC 1,200,000$9,708,0001.50%
RA Capital Management 7,000,000$56,630,0001.21%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,528,000$28,542,0001.18%
ACUTA CAPITAL PARTNERS, LLC 220,000$1,780,0000.77%
RTW INVESTMENTS, LP 3,985,910$32,246,0000.74%
BRANDYWINE MANAGERS, LLC 26,127$211,0000.69%
View complete list of FULCRUM THERAPEUTICS INC shareholders